Literature DB >> 15608417

Function and importance of p63 in normal oral mucosa and squamous cell carcinoma of the head and neck.

Niklas Thurfjell1, Philip J Coates, Linda Boldrup, Britta Lindgren, Bodil Bäcklund, Tony Uusitalo, David Mahani, Erik Dabelsteen, Ake Dahlqvist, Björn Sjöström, Göran Roos, Borek Vojtesek, Rudolf Nenutil, Karin Nylander.   

Abstract

BACKGROUND/AIMS: Squamous cell carcinoma of the head and neck (HNSCC) is the 6th most common malignancy worldwide with a 5-year survival that has not improved over the last 20-25 years. Factors of prognostic significance for this tumour type include the presence of regional lymph node metastasis and amplification of chromosome 3q21-29, where the p63 gene is located. This gene encodes 6 proteins and is crucial for formation of the oral mucosa, teeth, salivary glands and skin. Each of the 6 different p63 proteins has different characteristics and functions, where some resemble the tumour suppressor protein p53, whilst others have functions that oppose p53.
METHODS: To understand the function and importance of p63 in oral mucosa and tumour development we have studied protein as well as mRNA expression in normal oral mucosa and tumours. RESULTS/
CONCLUSION: Expression of p63 proteins differs between the cell layers in normal oral mucosa, and primary HNSCC has a high expression level of p63 isoforms normally expressed in basal cells. Data suggest that p63 expression in HNSCC influences tumour cell differentiation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15608417     DOI: 10.1159/000082464

Source DB:  PubMed          Journal:  Adv Otorhinolaryngol        ISSN: 0065-3071


  6 in total

1.  ΔNp63 expression in four carcinoma cell lines and the effect on radioresistance--a siRNA knockdown model.

Authors:  Maximilian Moergel; Jutta Goldschmitt; Marcus Stockinger; Martin Kunkel
Journal:  Clin Oral Investig       Date:  2013-08-15       Impact factor: 3.573

2.  DeltaNp63 overexpression, alone and in combination with other biomarkers, predicts the development of oral cancer in patients with leukoplakia.

Authors:  Pierre Saintigny; Adel K El-Naggar; Vali Papadimitrakopoulou; Hening Ren; You-Hong Fan; Lei Feng; J Jack Lee; Edward S Kim; Waun Ki Hong; Scott M Lippman; Li Mao
Journal:  Clin Cancer Res       Date:  2009-09-22       Impact factor: 12.531

3.  The p63/p73 network mediates chemosensitivity to cisplatin in a biologically defined subset of primary breast cancers.

Authors:  Chee-Onn Leong; Nick Vidnovic; Maurice Phillip DeYoung; Dennis Sgroi; Leif W Ellisen
Journal:  J Clin Invest       Date:  2007-04-19       Impact factor: 14.808

4.  Cyclin L1 (CCNL1) gene alterations in human head and neck squamous cell carcinoma.

Authors:  D Muller; R Millon; S Théobald; T Hussenet; B Wasylyk; S du Manoir; J Abecassis
Journal:  Br J Cancer       Date:  2006-04-10       Impact factor: 7.640

5.  Co-expression of ING4 and P53 enhances hypopharyngeal cancer chemosensitivity to cisplatin in vivo.

Authors:  Xin Ren; Hao Liu; Mingjie Zhang; Mengjun Wang; Shiyin Ma
Journal:  Mol Med Rep       Date:  2016-07-27       Impact factor: 2.952

6.  Oral cancer prognosis based on clinicopathologic and genomic markers using a hybrid of feature selection and machine learning methods.

Authors:  Siow-Wee Chang; Sameem Abdul-Kareem; Amir Feisal Merican; Rosnah Binti Zain
Journal:  BMC Bioinformatics       Date:  2013-05-31       Impact factor: 3.169

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.